Hakan stated when asked about what his opinion was on script growth, he replied that with all the initiatives underway and to begin, he expected significant uptake after September thru the end of the year.
Also they said SNY was doing research on a world launch, not just one country at a time, and would be disclosing soon.
He would have a meeting with SNY and tell them "we are not here to be a part of your diabetes ecosystem". If sales do not dramatically improve by the end of the year I am purging the dummy Al's deal here and I will partner with Pfiizer and we will give you all your money back with interest and then over the next 10 years we will take the lion share of the diabetes market away from you." So you have better get a clue and a priority because Jan 1 is not that far away.
Good theory. SNY is doing their own real world study right now. They will know long before the FDA in Jan. what is on the table here for extending the label. From a buyout perspective, buy out AL before the real world data is born out in 2016. If Afrezza is to become best selling drug greater than 140 billion per Lipitor give AL 30 billion for Afrezza as the drug will likely sell over 200 billion. AL needs to get paid so pay him $75.00 per share.
..when he started badmouthing Donald Trump I immediately stopped reading what this CLOWN has to say. He is a progressive liberal directly responsible for the decline of this country and the cultural rot. He does not know anything. He should be held accountable for his stupid article about MNKD but all will be forgotten when MNKD goes for $100 plus a share. David Cliff the low-life.
The big fix is get the drug to tier 1 and expand the label as they are doing. Then go global all at once = major flash point in stock price. My opinion is MNKD will be the darling of theJanuary Effect 2016 and without Trump. We need Donald Trump as President instead.
also Toujeo is going to get competition from the generic Lantus drugs that are going to be much much cheaper. I think this is why SNY pushed their drug. As the years go by, it is MNKD's afrezza that will be the exclusive money maker. Nothing can touch Afrezza, the world's first 200 billion dollar drug.
Why not Pfizer? Sanofi has had its chance. Afrezza needs to be marketed as stand alone. Pay shareholders 12and then make a trillion. If I were running this thing, that's what I would do if sanofi didnt get busy.
Setting up for the big long explosion. Don't pay any attention to H. Clinton, she will sell out for just a couple of million. Clintons always take democrat voters as fools, which they are.
yes there is. People want to see real growth in revenue and scripts. Until the company really does a WOW, MNKD is going to be a BOW-WOW. Wall Street gets real excited about explosive growth not explosive expectations when the company has reached commercial status. They want proof. It is time to show them or not show them.
Americans are stupid! They keep electing the same old politicians who lie and do what they want to do. Never ever vote them out. It should be one candidate for a term and then another one. Trump is better than anything in office or running.
since no one even knows about Afrezza yet, you may be premature here. SNY is in on the label update study to show drug's superior results. Why if they are going to dump?. I will say this, if nothing happens in 2016 and we are still here in the same place this time next year, I should have listened to you. Something has to give as MNKD's finances can't run forever without product revenue or milestone payments. After all this effort, I would not even want to see another secondary or even talk about it.. Time to roll or roll up.
put this drug on TV with a very good encouraging commercial and demonstration, cross reference a special web page so all users (500 scriptures get in there first) and interested parties can participate in, and tell them to go to their doctor and immediately request this remarkable drug. Just give it a try! And What diabetic would not try it? Send them knocking on the doors. This is how I would do it. Trusting Drs. only goes so far.
You do not know anything and probably a Boomer. Dumb brainwashed liberal who deserves civil rights be taken away. I would love to put you in your own country and come back in 50 years just so the both of us could agree how stupid you are.
Until they get the label changed, the stock price will look deflated. SNY will not commit the real high energy until they get the label changed. Until then they will do some education, some gradual script growth, some advertising, get inventory in hand and call all this a "soft launch". The CC is going to look ditto. MNKD cannot get beyond the proof of concept stage. Everything is on hold, dead money, losing money until script growth does bust a move out - I think first half next year. Tired of watching the grass grow but with superior insulin as advertised, then the push can begin. I think this fact is also holding them back going international as well. Stock needs some real news and none is coming out. The only other thing SNY buys out MNKD before the big push begins.
he got screwed with mankind as he urged his viewers to buy, buy, buy just ahead of the second trial failure. He is an enemy of MNKD as many are who lost money over the last ten years. But the ship has come in and it is tied up at the dock for a couple of months so all believers can now get on board at a low price. When this stock goes over $100. it will be one of the greatest stories of all time for woulda, coulda, didn't. crowd (Cramer will recommend at $100.)